Sublingual immunotherapy: where do we stand? Present and future

被引：14
作者：
Passalacqua, Giovanni [2 ]
Pawankar, Ruby [1 ]
Baena-Cagnani, Carlos E. [2 ,3 ]
Canonica, Giorgio Walter [2 ]
机构：
[1] Nippon Med Sch, Dept Otolaryngol, Tokyo 1138603, Japan
[2] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy
[3] Catholic Univ Cordoba, Fac Med, Cordoba, Argentina
来源：
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 9卷 / 01期
关键词：
POLLEN INDUCED RHINOCONJUNCTIVITIS; ALLERGIC RHINITIS; RESPIRATORY ALLERGY; COST-EFFECTIVENESS; DOUBLE-BLIND; ARIA UPDATE; FOLLOW-UP; ASTHMA; CHILDREN; COLLABORATION;
D O I：
10.1097/ACI.0b013e3283196a9b
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 32 条
  • [1] AGOSTINIS M, 2008, ALLERGY IN PRESS
  • [2] Cost-effectiveness of grass allergen tablet (GRAZAX®) for the prevention of seasonal grass pollen induced rhinoconjunctivitis -: a Northern European perspective
    Bachert, C.
    Vestenbaek, U.
    Christensen, J.
    Griffiths, U. K.
    Poulsen, P. B.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (05) : 772 - 779
  • [3] Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study
    Berto, Patrizia
    Passalacqua, Giovanni
    Crimi, Nunzio
    Frati, Franco
    Ortolani, Claudio
    Senna, Gianenrico
    Canonica, Giorgio Walter
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (05) : 615 - 621
  • [4] Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation
    Bohle, Barbara
    Kinaciyan, Tamar
    Gerstmayr, Marianne
    Radakovics, Astrid
    Jahn-Schmid, Beatrice
    Ebner, Christof
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 707 - 713
  • [5] Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen)
    Bousquet, J.
    Khaltaev, N.
    Cruz, A. A.
    Denburg, J.
    Fokkens, W. J.
    Togias, A.
    Zuberbier, T.
    Baena-Cagnani, C. E.
    Canonica, G. W.
    van Weel, C.
    Agache, I.
    Ait-Khaled, N.
    Bachert, C.
    Blaiss, M. S.
    Bonini, S.
    Boulet, L. -P.
    Bousquet, P. -J.
    Camargos, P.
    Carlsen, K. -H.
    Chen, Y.
    Custovic, A.
    Dahl, R.
    Demoly, P.
    Douagui, H.
    Durham, S. R.
    van Wijk, R. Gerth
    Kalayci, O.
    Kaliner, M. A.
    Kim, Y. -Y.
    Kowalski, M. L.
    Kuna, P.
    Le, L. T. T.
    Lemiere, C.
    Li, J.
    Lockey, R. F.
    Mavale-Manuel, S.
    Meltzer, E. O.
    Mohammad, Y.
    Mullol, J.
    Naclerio, R.
    Hehir, R. E. O.
    Ohta, K.
    Ouedraogo, S.
    Palkonen, S.
    Papadopoulos, N.
    Passalacqua, G.
    Pawankar, R.
    Popov, T. A.
    Rabe, K. F.
    Rosado-Pinto, J.
    [J]. ALLERGY, 2008, 63 : 8 - +
  • [6] Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)
    Bousquet, J.
    van Cauwenberge, P.
    Khaled, N. Ait
    Bachert, C.
    Baena-Cagnani, C. E.
    Bouchard, J.
    Bunnag, C.
    Canonica, G. W.
    Carlsen, K. -H.
    Chen, Y. -Z.
    Cruz, A. A.
    Custovic, A.
    Demoly, P.
    Dubakiene, R.
    Durham, S.
    Fokkens, W.
    Howarth, P.
    Kemp, J.
    Kowalski, M. L.
    Kvedariene, V.
    Lipworth, B.
    Lockey, R.
    Lund, V.
    Mavale-Manuel, S.
    Meltzer, E. O.
    Mullol, J.
    Naclerio, R.
    Nekam, K.
    Ohta, K.
    Papadopoulos, N.
    Passalacqua, G.
    Pawankar, R.
    Popov, T.
    Potter, P.
    Price, D.
    Scadding, G.
    Simons, F. E. R.
    Spicak, V.
    Valovirta, E.
    Wang, D. -Y.
    Yawn, B.
    Yusuf, O.
    [J]. ALLERGY, 2006, 61 (09) : 1086 - 1096
  • [7] Methodology for development of the Allergic Rhinitis and its Impact on Asthma Guideline 2008 update
    Brozek, J. L.
    Baena-Cagnani, C. E.
    Bonini, S.
    Canonica, G. W.
    Rasi, G.
    van Wijk, R. G.
    Zuberbier, T.
    Guyatt, G.
    Bousquet, J.
    Schuenemann, H. J.
    [J]. ALLERGY, 2008, 63 (01) : 38 - 46
  • [8] Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy
    Calderon, M. A.
    Birk, A. O.
    Andersen, J. S.
    Durham, S. R.
    [J]. ALLERGY, 2007, 62 (08) : 958 - 961
  • [9] Cost-effectiveness of GRAZAX® for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe
    Canonica, G. W.
    Poulsen, P. B.
    Vestenbaek, U.
    [J]. RESPIRATORY MEDICINE, 2007, 101 (09) : 1885 - 1894
  • [10] Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
    Canonica, G. W.
    Baena-Cagnani, C. E.
    Bousquet, J.
    Bousquet, P. J.
    Lockey, R. F.
    Malling, H. -J.
    Passalacqua, G.
    Potter, P.
    Valovirta, E.
    [J]. ALLERGY, 2007, 62 (03) : 317 - 324
1234